a multicenter trial was proposed to test the hypothesis that in iddm two levels of mean glycemia , sufficiently separated to examine the control/complications relationship , could be maintained by the six collaborating centers , using randomized patient allocation to conventional insulin therapy ( cit ) and continuous subcutaneous insulin infusion ( csii ) as the alternative treatment modalities .
C0011854
iddm
C0021641
insulin